Pregnancy News and Research

Latest Pregnancy News and Research

SRI International awarded $3.8M BARDA contract to develop a radiation assessment device

SRI International, an independent nonprofit research and development institute, has received a $3.8M contract from the Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA). SRI will research and develop a device to triage individuals who may have been exposed to ionizing radiation after a radiological or nuclear incident.

24 Feb 2010

Forest Laboratories' Bystolic tablets for treatment of stable CHF failed to receive FDA approval

Forest Laboratories, Inc. announced today that the U.S. Food and Drug Administration did not approve the additional indication for Bystolic® (nebivolol) tablets as a treatment for stable chronic heart failure (CHF) as requested in the company’s Supplemental New Drug Application (sNDA).

23 Feb 2010

FDA grants Diagnostic Hybrids emergency use authorization for 2009 H1N1 Influenza A Virus ID Kit

Diagnostic Hybrids, a Quidel Company has received emergency use authorization from the U.S. Food and Drug Administration for its D3® UltraTM 2009 H1N1 Influenza A Virus ID Kit, a monoclonal antibody fluorescent staining kit for the specific identification of 2009 H1N1 influenza A in direct patient specimens or incubated tissue cultures.

23 Feb 2010

Prevention of preterm birth and stillbirth: Global collaborative efforts needed

A new report identifies the enormous global impact of preterm birth and stillbirth—and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000. Additionally, an estimated 3.2 million are stillborn each year, and many of these losses are linked to maternal deaths.

23 Feb 2010

Genentech's Avastin combination Phase III study in advanced stomach cancer does not meet primary endpoint

Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study (AVAGAST) did not meet its primary endpoint of showing Avastin® (bevacizumab) plus Xeloda® (capecitabine) or 5-FU and cisplatin chemotherapy extended the lives of people with inoperable or advanced stomach (gastric) cancer, compared to chemotherapy alone.

23 Feb 2010

Excessive weight gain during pregnancy linked to increased risk of gestational diabetes

Women who gain excessive weight during pregnancy, especially in the first trimester, may increase their risk of developing diabetes later in their pregnancy, according to a study by the Kaiser Permanente Division of Research that appears online in the current issue of Obstetrics and Gynecology.

23 Feb 2010

Global report identifies causes leading to preterm births and stillbirths

More research and attention are urgently needed to understand and reduce the incidence of preterm births and stillbirths worldwide, according to experts from the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS).

23 Feb 2010

Six scientists to study causes of preterm birth supported by funding from March Of Dimes

The March of Dimes has committed another $2.6 million to support the work of six scientists for the next three years as they study the causes of preterm birth. The 2010 grants bring the six-year total of the March of Dimes Prematurity Research Initiative grant program to more than $15 million.

23 Feb 2010

Black women are more prone to peripartum cardiomyopathy around childbirth time

A study examining the incidence of peripartum cardiomyopathy in women who gave birth at a Medical College of Georgia's teaching hospital between July 2003 and July 2008, showed that while 55 percent of the women were white, 93 percent of those who developed cardiomyopathy were black, said Dr. Mindy B. Gentry, an MCG cardiologist.

23 Feb 2010

AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps

A new guideline from the American Academy of Neurology recommends that the drug quinine, although effective, should be avoided for treatment of routine muscle cramps due to uncommon but serious side effects.

23 Feb 2010

Opinion: Violence against women, rebuilding Haiti, food security

"Violence against women is a global epidemic, threatening the lives and safety of women and girls around the world," Sen. Benjamin Cardin (D-Md.), chairman of the U.S. Helsinki Commission, writes in a Baltimore Sun opinion piece in which he asserts his support of the International Violence Against Women Act. In the piece, Cardin describes how violence against women increases risks of health problems - such as dying in pregnancy and contracting HIV - and poverty (2/19).

20 Feb 2010

Quidel acquires Diagnostic Hybrids for $130 million

Quidel Corporation, a leading provider of rapid diagnostic tests, has completed its previously announced acquisition of Diagnostic Hybrids, Inc. for approximately $130 million in cash.

20 Feb 2010

10th Annual Conference for Young Women Affected by Breast Cancer

Young women diagnosed with breast cancer are uniquely impacted by issues often not faced by older women. Breast cancer is often detected at later stages, increasing diagnoses of more advanced cancers. The impact of cancer treatment on fertility, body image, financial challenges, and slightly higher mortality rates are significant concerns for this population.

19 Feb 2010

Patient registry formed to track clinical course of hypoactive sexual desire disorder

New findings from a European study show that women with low sexual desire and associated distress experience personal and emotional distress related to the sexual issue.

19 Feb 2010

Group B streptococcus may have significant public health implications: Study

A common bacteria found in many healthy adult females that can cause life-threatening infections when passed to newborns could be introduced to some women through frequent contact with cows, according to a research team led by a Michigan State University pediatrician.

19 Feb 2010

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

19 Feb 2010

Efficient healthcare system in sub-Saharan Africa can reduce maternal deaths

More than 500,000 women die each year worldwide due to complications arising from pregnancy and childbirth. Half of these women live in sub-Saharan Africa. A research team from the King Juan Carlos University (URJC) in Madrid says these women are not dying as a result of any illness, but rather from a lack of basic healthcare measures.

19 Feb 2010

Steroids and weight loss products can accelerate hair loss, says hair loss expert

In a study due to be released next month, the world's leading hair transplant and hair loss expert Dr. Larry Shapiro will show that men and women have been losing their hair from using popular weight loss and work out products that contain whey protein isolate- and it's not just their genes that are to blame.

19 Feb 2010

Revised and updated edition of Toole's Cerebrovascular Disorders textbook now available

Since it was published more than 40 years ago, Toole's Cerebrovascular Disorders has been a standard textbook for the prevention, diagnosis and treatment of strokes.

18 Feb 2010

UCSF receives $1.15M grant to integrate family planning into HIV treatment and care

UCSF has received a $1.15 million grant from the Bill & Melinda Gates Foundation to determine if integrating family planning into HIV treatment and care will increase contraceptive use and decrease unintended pregnancy among HIV-positive women. UCSF will partner with the Kenya Medical Research Institute and Ibis Reproductive Health to conduct the research.

18 Feb 2010

Pregnancy News and Research

Latest Pregnancy News and Research

SRI International awarded $3.8M BARDA contract to develop a radiation assessment device

Forest Laboratories' Bystolic tablets for treatment of stable CHF failed to receive FDA approval

FDA grants Diagnostic Hybrids emergency use authorization for 2009 H1N1 Influenza A Virus ID Kit

Prevention of preterm birth and stillbirth: Global collaborative efforts needed

Genentech's Avastin combination Phase III study in advanced stomach cancer does not meet primary endpoint

Excessive weight gain during pregnancy linked to increased risk of gestational diabetes

Global report identifies causes leading to preterm births and stillbirths

Six scientists to study causes of preterm birth supported by funding from March Of Dimes

Black women are more prone to peripartum cardiomyopathy around childbirth time

AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps

Opinion: Violence against women, rebuilding Haiti, food security

Quidel acquires Diagnostic Hybrids for $130 million

10th Annual Conference for Young Women Affected by Breast Cancer

Patient registry formed to track clinical course of hypoactive sexual desire disorder

Group B streptococcus may have significant public health implications: Study

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Efficient healthcare system in sub-Saharan Africa can reduce maternal deaths

Steroids and weight loss products can accelerate hair loss, says hair loss expert

Revised and updated edition of Toole's Cerebrovascular Disorders textbook now available

UCSF receives $1.15M grant to integrate family planning into HIV treatment and care

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Pregnancy News and Research

Latest Pregnancy News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in